Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Alzheimer's Association Statement on Lecanemab Phase 3 Full Results
The Alzheimer’s Association welcomes, and is further encouraged by the full Phase 3 data presented […]
TrialSpark Announces Acquisition of a Clinical-stage Immunodermatology Portfolio and Formation of Libertas Bio
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position […]
PhRMA Foundation Announces New Members of Board of Directors
The PhRMA Foundation has announced the appointment to its Board of Directors of Aida Habtezion, MD, […]
Bryn Pharma Strengthens Board of Directors with Appointments of Commercial Veterans Sandy Loreaux and William D. Humphries
Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for […]
pVerify Releases Salesforce App for Durable Medical Equipment Suppliers
pVerify, Inc, the leader in all-payer real-time patient insurance eligibility via API and cloud-based portal […]
Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute
Turnstone Biologics Corp, a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid […]
New Funding of $2 Million for Research Bringing Us One Step Closer to a Cure for Follicular Lymphoma
The Follicular Lymphoma Foundation (FLF) today announced it has awarded four research grants of up to […]
TargEDys and SymbioPharm Enter an Exclusive Partnership to launch SymbioLife® Satylia® in Germany
TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife® […]
Audax Private Equity Announces Acquisition of Medi-Weightloss, Inc.
Audax Private Equity announced the acquisition of Medi-Weightloss, a leading operator of science-based, physician-supervised weight-loss […]
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
Full-Life Technologies, a fully integrated global radiotherapeutics company, today announced an agreement to acquire New Jersey-based […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more